HK1201761A1 - Functionalization of biomaterials to control regeneration and inflammation responses - Google Patents
Functionalization of biomaterials to control regeneration and inflammation responsesInfo
- Publication number
- HK1201761A1 HK1201761A1 HK15102410.1A HK15102410A HK1201761A1 HK 1201761 A1 HK1201761 A1 HK 1201761A1 HK 15102410 A HK15102410 A HK 15102410A HK 1201761 A1 HK1201761 A1 HK 1201761A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- biomaterials
- functionalization
- control regeneration
- inflammation responses
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161581364P | 2011-12-29 | 2011-12-29 | |
PCT/US2012/072275 WO2013102193A1 (en) | 2011-12-29 | 2012-12-31 | Functionalization of biomaterials to control regeneration and inflammation responses |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201761A1 true HK1201761A1 (en) | 2015-09-11 |
Family
ID=48698691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102410.1A HK1201761A1 (en) | 2011-12-29 | 2015-03-10 | Functionalization of biomaterials to control regeneration and inflammation responses |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150010630A1 (pt) |
EP (1) | EP2797641B1 (pt) |
KR (1) | KR20140108705A (pt) |
BR (1) | BR112014016154A8 (pt) |
CA (1) | CA2865796A1 (pt) |
HK (1) | HK1201761A1 (pt) |
WO (1) | WO2013102193A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201113856D0 (en) * | 2011-08-11 | 2011-09-28 | Oxford Biomaterials Ltd | Medical device |
EP3036098A1 (en) * | 2013-08-22 | 2016-06-29 | Allergan, Inc. | Implantable medical devices |
US20160199450A1 (en) * | 2013-08-26 | 2016-07-14 | The Trustees Of Columbia University In The City Of New York | Scaffolds containing cytokines for tissue engineering |
WO2015054125A1 (en) * | 2013-10-08 | 2015-04-16 | Trustees Of Tufts College | Tunable covalently crosslinked hydrogels and methods of making the same |
WO2015077401A1 (en) | 2013-11-20 | 2015-05-28 | Drexel University | Compositions and methods for macrophage conversion |
EP3074507B1 (en) | 2013-11-26 | 2022-01-05 | Biomet Biologics, LLC | Methods of mediating macrophage phenotypes |
GB201415681D0 (en) | 2014-09-04 | 2014-10-22 | Cambridge Entpr Ltd And President And Fellows Of Harvard College | Protien Capsules |
WO2017075136A1 (en) * | 2015-10-27 | 2017-05-04 | Purdue Research Foundation | Polymer-based therapeutics for inductive browning of fat |
WO2018081815A2 (en) | 2016-10-31 | 2018-05-03 | Sofregen Medical, Inc. | Compositions comprising silk fibroin particles and uses thereof |
WO2018095264A1 (zh) * | 2016-11-22 | 2018-05-31 | 陈艳丽 | Notch信号通路调控剂调节骨生成 |
US20200054796A1 (en) * | 2017-02-21 | 2020-02-20 | Trustees Of Tufts College | Silk Fibroin Tracheal Stent |
EP3630215A1 (en) * | 2017-05-26 | 2020-04-08 | Association for the Advancement of Tissue Engineering and Cell based Technologies & Therapies (A4TEC) - Associação | Ionic-doped composition methods and uses thereof |
US20210236644A1 (en) | 2017-11-10 | 2021-08-05 | Cocoon Biotech Inc. | Ocular applications of silk-based products |
US11773533B2 (en) * | 2017-12-05 | 2023-10-03 | Università degli Studi di Roma “La Sapienza” | Composition for use in the finishing, preservation, restoration of manufactures |
WO2019139892A1 (en) * | 2018-01-12 | 2019-07-18 | President And Fellows Of Harvard College | Compositions and methods relating to macrophages and/or monocytes with adhered particles |
EP4045124A4 (en) | 2019-10-15 | 2024-01-24 | Sofregen Medical Inc | DISPENSING DEVICES FOR DISPENSING AND METHOD FOR DISPENSING COMPOSITIONS |
CN111888522B (zh) * | 2020-09-22 | 2022-12-20 | 中山大学附属口腔医院 | 一种具有免疫调控功能的牙周再生材料及其制备方法 |
CN112451732A (zh) * | 2020-11-27 | 2021-03-09 | 山东大学 | 一种单侧负载银的丝素蛋白抗菌敷料及制备方法和应用 |
CN115487350B (zh) * | 2021-06-17 | 2023-10-31 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种调节免疫炎症微环境水凝胶支架及其制备方法和应用 |
CN113813445A (zh) * | 2021-10-08 | 2021-12-21 | 苏州大学 | 一种丝素蛋白复合多孔支架及其制备方法 |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5612114B2 (pt) | 1974-06-07 | 1981-03-18 | ||
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
AU548996B2 (en) | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
DK149080C (da) | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
WO1984002131A1 (en) | 1982-11-22 | 1984-06-07 | Sandoz Ag | Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
US4681893A (en) | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
JP2569746B2 (ja) | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
US5753675A (en) | 1989-03-03 | 1998-05-19 | Novartis Pharmaceuticals Corporation | Quinoline analogs of mevalonolactone and derivatives thereof |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
US5245012A (en) | 1990-04-19 | 1993-09-14 | The United States Of America As Represented By The Secretary Of The Army | Method to achieve solubilization of spider silk proteins |
US5177080A (en) | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
EP0617706B1 (en) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalent antigen-binding proteins |
WO1996013275A1 (en) * | 1994-10-31 | 1996-05-09 | Tkb Associates Limited Partnership | Methods and products for enhancing immune responses |
EP0848754A1 (en) | 1995-08-22 | 1998-06-24 | Richard M. Basel | Cloning methods for high strength spider silk proteins |
US6841543B1 (en) * | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
KR100431659B1 (ko) | 1997-06-18 | 2004-05-17 | 독립행정법인농업생물자원연구소 | 견 피브로인 및 견 세리신을 주성분으로 하는 창상피복재 및 그의 제조방법 |
US6287340B1 (en) | 1999-05-14 | 2001-09-11 | Trustees Of Tufts College | Bioengineered anterior cruciate ligament |
JP2001163899A (ja) | 1999-12-09 | 2001-06-19 | Natl Inst Of Sericultural & Entomological Science | 機能性絹フィブロインの製造方法とその利用 |
US6902932B2 (en) | 2001-11-16 | 2005-06-07 | Tissue Regeneration, Inc. | Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
US20110009960A1 (en) | 2001-11-16 | 2011-01-13 | Allergan, Inc. | Prosthetic fabric structure |
WO2004001103A2 (en) | 2002-06-24 | 2003-12-31 | Tufts University | Silk biomaterials and methods of use thereof |
JP4638735B2 (ja) | 2002-06-24 | 2011-02-23 | タフツ ユニバーシティー | 絹糸生体材料およびその使用方法 |
WO2004062697A2 (en) * | 2003-01-07 | 2004-07-29 | Tufts University | Silk fibroin materials and use thereof |
JP4698596B2 (ja) | 2003-04-10 | 2011-06-08 | タフツ ユニバーシティー | 濃縮された水性シルクフィブロイン溶液およびそれらの使用 |
WO2005000483A1 (en) | 2003-06-06 | 2005-01-06 | Tufts University | Method for forming inorganic coatings |
CA3075158A1 (en) | 2004-06-11 | 2005-12-29 | Trustees Of Tufts College | Silk-based drug delivery system |
WO2006042287A2 (en) | 2004-10-12 | 2006-04-20 | Trustees Of Tufts College | Method for producing biomaterial scaffolds |
US7960509B2 (en) | 2005-01-14 | 2011-06-14 | Trustees Of Tufts College | Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials |
US9290579B2 (en) | 2005-04-20 | 2016-03-22 | Trustees Of Tufts College | Covalently immobilized protein gradients in three-dimensional porous scaffolds |
CA2645934C (en) | 2005-08-02 | 2014-04-29 | Trustees Of Tufts College | Methods for stepwise deposition of silk fibroin coatings |
US20080038236A1 (en) | 2006-03-06 | 2008-02-14 | Artecel Sciences, Inc. | Biocompatible scaffolds and adipose-derived stem cells |
US20100028451A1 (en) * | 2006-09-26 | 2010-02-04 | Trustees Of Tufts College | Silk microspheres for encapsulation and controlled release |
EP2109634A2 (en) | 2006-11-03 | 2009-10-21 | Trustees of the Tufts College | Electroactive biopolymer optical and electro-optical devices and method of manufacturing the same |
WO2008118211A2 (en) | 2006-11-03 | 2008-10-02 | Trustees Of Tufts College | Biopolymer photonic crystals and method of manufacturing the same |
US20100068740A1 (en) | 2006-11-03 | 2010-03-18 | Trustees Of Tufts College | Microfluidic device with a cylindrical microchannel and a method for fabricating same |
CA2704769C (en) | 2006-11-03 | 2016-01-12 | Trustees Of Tufts College | Nanopatterned biopolymer optical device and method of manufacturing the same |
CA2704768A1 (en) | 2006-11-03 | 2008-10-23 | Trustees Of Tufts College | Biopolymer sensor and method of manufacturing the same |
US8975073B2 (en) | 2006-11-21 | 2015-03-10 | The Charles Stark Draper Laboratory, Inc. | Microfluidic device comprising silk films coupled to form a microchannel |
WO2008085904A1 (en) | 2007-01-05 | 2008-07-17 | Charles Stark Draper Laboratory, Inc. | Biodegradable electronic devices |
WO2008103392A2 (en) * | 2007-02-21 | 2008-08-28 | Vaccinex, Inc. | Modulation of nkt cell activity with antigen-loaded cdid molecules |
US9102916B2 (en) | 2007-02-27 | 2015-08-11 | Trustees Of Tufts College | Tissue-engineered silk organs |
PT2211876E (pt) | 2007-05-29 | 2015-01-14 | Tufts College | Método de gelificação de fibroína de seda utilizando sonicação |
CA2742844C (en) | 2007-11-05 | 2017-02-28 | Trustees Of Tufts College | Fabrication of silk fibroin photonic structures by nanocontact imprinting |
US20110218143A1 (en) * | 2007-11-20 | 2011-09-08 | University Of Florida Research Foundation | Compositions and methods for tissue repair |
US9504575B2 (en) | 2008-02-07 | 2016-11-29 | Trustees Of Tufts College | 3-dimensional silk hydroxyapatite compositions |
US8206774B2 (en) | 2008-03-13 | 2012-06-26 | Trustees Of Tufts College | Diazonium salt modification of silk polymer |
WO2009126689A2 (en) | 2008-04-08 | 2009-10-15 | Trustees Of Tufts College | System and method for making biomaterial structures |
US20110135697A1 (en) | 2008-06-18 | 2011-06-09 | Trustees Of Tufts College | Edible holographic silk products |
US8976938B2 (en) * | 2008-07-07 | 2015-03-10 | Centurylink Intellectual Property Llc | Deluxe emergency notification |
US8501172B2 (en) | 2008-09-26 | 2013-08-06 | Trustees Of Tufts College | pH-induced silk gels and uses thereof |
CN105268020A (zh) | 2008-10-09 | 2016-01-27 | 塔夫茨大学信托人 | 含有甘油的改性丝膜 |
US9427499B2 (en) | 2008-11-17 | 2016-08-30 | Trustees Of Tufts College | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials |
CN103590177B (zh) | 2008-12-15 | 2017-01-04 | 阿勒根公司 | 制造用于假体装置的编织网的方法 |
EP2403551A4 (en) * | 2009-03-04 | 2014-02-26 | Tufts College | FIBROIN SILK SYSTEMS FOR ANTIBIOTIC DELIVERY |
EP2421549B1 (en) | 2009-04-20 | 2013-06-12 | Allergan, Inc. | Silk fibroin hydrogels and uses thereof |
US20110111031A1 (en) | 2009-04-20 | 2011-05-12 | Guang-Liang Jiang | Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
US20110052695A1 (en) | 2009-04-20 | 2011-03-03 | Allergan, Inc. | Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
WO2011005381A2 (en) | 2009-06-01 | 2011-01-13 | Trustees Of Tufts College | Vortex-induced silk fibroin gelation for encapsulation and delivery |
EP2451953A4 (en) | 2009-07-10 | 2013-07-03 | Tufts College | GEN-MANIPULATED SILK PROTEIN-BASED NUCLEIC ACID DELIVERY SYSTEMS |
US8293486B2 (en) | 2009-07-21 | 2012-10-23 | Trustees Of Tufts College | Functionalization of silk material by avidin-biotin interaction |
CA2773956A1 (en) | 2009-09-11 | 2011-03-17 | Allergan, Inc. | Prosthetic device and method of manufacturing the same |
CN101891962B (zh) * | 2010-07-22 | 2012-06-06 | 苏州大学 | 丝素蛋白多孔三维材料的制备方法 |
EP2611492A2 (en) | 2010-09-03 | 2013-07-10 | Tufts University/Trustees of Tufts College | Plasmonic nanoparticle-doped silk materials |
US20140378661A1 (en) | 2011-04-20 | 2014-12-25 | Trustees Of Tufts College | Molded regenerated silk geometries using temperature control and mechanical processing |
-
2012
- 2012-12-31 CA CA2865796A patent/CA2865796A1/en not_active Abandoned
- 2012-12-31 WO PCT/US2012/072275 patent/WO2013102193A1/en active Application Filing
- 2012-12-31 EP EP12862472.3A patent/EP2797641B1/en active Active
- 2012-12-31 KR KR1020147020822A patent/KR20140108705A/ko not_active Application Discontinuation
- 2012-12-31 BR BR112014016154A patent/BR112014016154A8/pt not_active IP Right Cessation
- 2012-12-31 US US14/369,658 patent/US20150010630A1/en not_active Abandoned
-
2015
- 2015-03-10 HK HK15102410.1A patent/HK1201761A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013102193A1 (en) | 2013-07-04 |
US20150010630A1 (en) | 2015-01-08 |
EP2797641A4 (en) | 2015-07-29 |
EP2797641B1 (en) | 2019-07-10 |
CA2865796A1 (en) | 2013-07-04 |
BR112014016154A8 (pt) | 2017-07-04 |
BR112014016154A2 (pt) | 2017-06-13 |
KR20140108705A (ko) | 2014-09-12 |
EP2797641A1 (en) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1201761A1 (en) | Functionalization of biomaterials to control regeneration and inflammation responses | |
EP2717931A4 (en) | ASSOCIATIONS AND RELATED METHODS | |
HK1183427A1 (zh) | 吸收性物品和製造吸收性物品的方法 | |
IL226401A0 (en) | Methods for treating disorders related to @fgfBA | |
IL269166A (en) | Methods and preparations for treating inflammation | |
SG11201403276TA (en) | Modified microorganisms and methods of making butadiene using same | |
EP2742051A4 (en) | AMORPHIC FORM OF DOLUTEGRAVIR | |
EP2717926A4 (en) | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING BIOFILMS | |
EP2684167A4 (en) | COMPOSITIONS AND METHODS USEFUL IN THE TREATMENT OF DISEASES | |
PL2747724T3 (pl) | Sposób nakładania elementów strukturalnych na wyrób chłonny | |
HK1205759A1 (en) | Treatment of biomass | |
HK1199015A1 (en) | Treatment of inflammation | |
HUE039748T2 (hu) | Akuszto-optikai deflektorokat szabályozó módszerek és berendezések | |
PL2682409T3 (pl) | Pochodna kwasu hialuronowego zmodyfikowana kwasem aminokarboksylowym | |
EP2909374A4 (en) | Novel creping adhesives and method for monitoring and controlling their use | |
ZA201404281B (en) | Methods and products to diagnose and treat heatiness | |
EP2699198A4 (en) | BIODEGRADABLE MEDICAL DEVICES AND METHOD FOR CONTROLLING DEGRADATION OF SAID BIODEGRADABLE MEDICAL DEVICES | |
EP2538964A4 (en) | MODULATION OF CYTOKININDUCED CHRONIC INFLAMMATORY REACTIONS | |
EP2888395A4 (en) | METHODS AND APPARATUS FOR ASSEMBLING ACTUATORS | |
ZA201309109B (en) | Methods of treating biomass | |
ZA201307230B (en) | Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma-glutamyl-l-tryptophan | |
GB201103053D0 (en) | Voltage adaption unit and method of use thereof | |
GB201117562D0 (en) | Improving to and relating to toothbrushes | |
IL231452A (en) | An amorphous form of a dolotgrave | |
GB201100651D0 (en) | Treatment of inflammation |